Neurodegenerative Diseases

Ten years of work by researchers from the University of Melbourne's, Bio21 Molecular Science and Biotechnology Institute and the Florey Institute of Neuroscience and Mental Health, a human trial for a drug that could fight Motor Neurone Disease has begun.

Renowned scientist and Bio21 Institute researcher Professor Michael Parker was recently published in Scientific Reports for his research into antibody treatments for Alzheimer’s Disease.